ArticleBioengineering (Basel, Switzerland)2023
Multimodal Stereotactic Brain Tumor Segmentation Using 3D-Znet.
Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Applications of Deep Neural Networks with Fractal Structure and Attention Blocks for 2D and 3D Brain Tumor Segmentation.Journal of statistical theory and practice · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stereotactic brain tumor segmentation based on 3D neuroimaging data is a challenging task due to the complexity of the brain architecture, extreme heterogeneity of tumor malformations, and the extreme variability of intensity signal and noise distributions. Early tumor diagnosis can help medical professionals to select optimal medical treatment plans that can potentially save lives. Artificial intelligence (AI) has previously been used for automated tumor diagnostics and segmentation models. However, the model development, validation, and reproducibility processes are challenging. Often, cumulative efforts are required to produce a fully automated and reliable computer-aided diagnostic system for tumor segmentation. This study proposes an enhanced deep neural network approach, the 3D-Znet model, based on the variational autoencoder-autodecoder Znet method, for segmenting 3D MR (magnetic resonance) volumes. The 3D-Znet artificial neural network architecture relies on fully dense connections to enable the reuse of features on multiple levels to improve model performance. It consists of four encoders and four decoders along with the initial input and the final output blocks. Encoder-decoder blocks in the network include double convolutional 3D layers, 3D batch normalization, and an activation function. These are followed by size normalization between inputs and outputs and network concatenation across the encoding and decoding branches. The proposed deep convolutional neural network model was trained and validated using a multimodal stereotactic neuroimaging dataset (BraTS2020) that includes multimodal tumor masks. Evaluation of the pretrained model resulted in the following dice coefficient scores: Whole Tumor (WT) = 0.91, Tumor Core (TC) = 0.85, and Enhanced Tumor (ET) = 0.86. The performance of the proposed 3D-Znet method is comparable to other state-of-the-art methods. Our protocol demonstrates the importance of data augmentation to avoid overfitting and enhance model performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.